Andy Stevenson
Technology Director at OLG Consulting- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Spanish Limited working proficiency
-
German Limited working proficiency
Topline Score
Bio
Experience
-
OLG Consulting
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
Technology Director
-
Nov 2017 - Present
Board member of OLGC and Non-executive Director of OLGE responsible for business development, technical leadership, process technology and BPE's process consultancy business portfolio in the Bioprocessing and high value manufacturing sectors. BEIS Vaccines Task Force Technical Team Lead working on current and long-term vaccine supply for the UK. Board member of OLGC and Non-executive Director of OLGE responsible for business development, technical leadership, process technology and BPE's process consultancy business portfolio in the Bioprocessing and high value manufacturing sectors. BEIS Vaccines Task Force Technical Team Lead working on current and long-term vaccine supply for the UK.
-
-
-
CSL
-
Australia
-
Biotechnology Research
-
700 & Above Employee
-
Head of Secondary Programmes
-
Nov 2015 - Oct 2017
Define and lead post acquisition strategy for major capex project investments and technology transfers including formulation and a flexible vaccine fill finish suite including automatic inspection, packaging and adjuvant preparation. Definition of manufacturing technology platforms and selection of equipment and vendors. Define and lead post acquisition strategy for major capex project investments and technology transfers including formulation and a flexible vaccine fill finish suite including automatic inspection, packaging and adjuvant preparation. Definition of manufacturing technology platforms and selection of equipment and vendors.
-
-
-
Novartis
-
Switzerland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Head of Secondary Programmes
-
May 2015 - Nov 2015
Lead the definition and execution of the Formulation, Fill & Finish capex investment strategy and manufacturing technology selection for major capex projects for seasonal and pandemic vaccine manufacture.Site Master Planning & Capex Programme Management.
-
-
Director of Engineering
-
Jul 2011 - May 2015
Site Leadership Team Head of Engineering responsible for leading the Engineering Group supporting high volume vaccine manufacturing; including the strategy for Site Master Planning, Process Engineering, Capital Projects, Maintenance & Reliability, Facilities, Automation & Control, Validation, Utilities and Effluent Treatment Functions on site.Member of the Global Engineering Technical Operations Leadership Team.Project Director for a new build microbial fermentation BioPharm plant. Group Biologics manufacturing SME.Sponsorship for Engineering & Technical staff management development programmes. Show less
-
-
-
Pfizer
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Process Engineering Manager
-
Jan 2008 - Jul 2011
Biologics technology SME leading technical teams in Drug Substance and Drug Product to support the technology transfer and operational optimisation of biopharmaceutical products including Enbrel and Prevenar 13 vaccine. Sponsorship and development of in-depth Bioprocessing Technical Training Programmes with NIBRT. Biologics technology SME leading technical teams in Drug Substance and Drug Product to support the technology transfer and operational optimisation of biopharmaceutical products including Enbrel and Prevenar 13 vaccine. Sponsorship and development of in-depth Bioprocessing Technical Training Programmes with NIBRT.
-
-
-
Amgen
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
PMO Senior Project Manager
-
Jan 2007 - Jul 2007
Programme management for operational readiness of a Greenfield biopharmaceutical campus. Programme management for operational readiness of a Greenfield biopharmaceutical campus.
-
-
-
-
Bioprocess Consultant
-
Sep 2003 - Dec 2006
Lead Capex and technology transfer projects for clients in the Biotechnology manufacturing and R&D sector. Lead Capex and technology transfer projects for clients in the Biotechnology manufacturing and R&D sector.
-
-
-
-
Project Manager
-
Jan 2002 - Apr 2003
Design - build- validation for biotechnology manufacturing and scale-up projects Design - build- validation for biotechnology manufacturing and scale-up projects
-
-
-
bp
-
United Kingdom
-
Oil and Gas
-
700 & Above Employee
-
Project Development Engineer
-
Apr 2001 - Jan 2002
Leading capital projects in large-scale petrochemicals. Leading capital projects in large-scale petrochemicals.
-
-
-
Unilever
-
United Kingdom
-
Manufacturing
-
700 & Above Employee
-
Project & Process Development Manager
-
Nov 1995 - Mar 2001
Site Leadership Team member for Capex project management, process design, continuous improvement and new product introduction in an Industrial Biotechnology food flavours site. Site Leadership Team member for Capex project management, process design, continuous improvement and new product introduction in an Industrial Biotechnology food flavours site.
-
-
-
-
Fermentation Scientist
-
Jul 1994 - Nov 1995
Commissioning, qualification, start-up and operation of monoclonal antibody cell culture plants for contract manufacturing Commissioning, qualification, start-up and operation of monoclonal antibody cell culture plants for contract manufacturing
-
-
-
Smith+Nephew
-
United Kingdom
-
Medical Equipment Manufacturing
-
700 & Above Employee
-
Development Scientist
-
Jan 1993 - Jul 1994
Process Development and NPI for sterile opthalmics,and oral medicines Process Development and NPI for sterile opthalmics,and oral medicines
-
-
Education
-
UCL
MSc, Biochemical Engineering -
Swansea University
BSc, Process Biotechnology